You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Phendimetrazine tartrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for phendimetrazine tartrate and what is the scope of patent protection?

Phendimetrazine tartrate is the generic ingredient in nineteen branded drugs marketed by Valeant, Numark, Graham Dm, Virtus, Shire Richwood, Mast Mm, Sandoz, Vitarine, Solvay, Teva, Ferndale Labs, Abc Holding, Camall, Chartwell Rx, Pvt Form, Forest Pharms, Barr, Chartwell, Elite Labs Inc, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Nexgen Pharma Inc, Nostrum Labs Inc, Upsher Smith Labs, Usl Pharma, Watson Labs, and Wyeth Ayerst, and is included in ninety-six NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for phendimetrazine tartrate. Twelve suppliers are listed for this compound.

Summary for phendimetrazine tartrate
Drug Prices for phendimetrazine tartrate

See drug prices for phendimetrazine tartrate

Pharmacology for phendimetrazine tartrate

US Patents and Regulatory Information for phendimetrazine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Virtus PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 018074-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 083993-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abc Holding PHENAZINE-35 phendimetrazine tartrate TABLET;ORAL 085512-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst PLEGINE phendimetrazine tartrate TABLET;ORAL 012248-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.